Clamor mounts over compromised care and rising costs due to lack of crucial therapies.
Nov 2, 2011
By:
Jill Wechsler
Clamor mounts over compromised care and rising costs due to lack of crucial therapies.
|
Manufacturers fund research and reduce prices to tackle diseases.
Oct 2, 2011
By:
Jill Wechsler
Manufacturers fund research and reduce prices to tackle diseases.
|
PDUFA renewal legislation sets stage for new policies affecting revenue, research, and oversight.
Sep 2, 2011
By:
Jill Wechsler
PDUFA renewal legislation sets stage for new policies affecting revenue, resarch, and oversight.
|
Rising imports and overseas production spur realignment of enforcement.
Aug 2, 2011
By:
Jill Wechsler
Rising imports and overseas production spur realignment of enforcement.
|
Follow-on versions of complex biologics require extensive expertise in development and regulatory procedures.
Jul 2, 2011
By:
Jill Wechsler
Follow-on versions of complex biologics require extensive expertise in development and regulatory procedures.
|
Industry struggles to curb drug abuse, diversion, and disruptions in supply.
Jun 2, 2011
By:
Jill Wechsler
Industry struggles to curb drug abuse, diversion, and disruptions in supply.
|
FDA, NIH and industry seek new strategies to spur drug development and promote access to therapies.
May 2, 2011
By:
Jill Wechsler
FDA, NIH and industry seek new strategies to spur drug development and promote access to therapies.
|
Courts and Congress seek to reshape policies and programs.
Apr 2, 2011
By:
Jill Wechsler
Courts and Congress seek to reshape policies and programs.
|
As drug shortages make headlines, FDA tests the Sentinel safety system and its efect on healthcare.
Mar 2, 2011
By:
Jill Wechsler
As drug shortages make headlines, FDA tests the Sentinel safety system and its efect on healthcare.
|
|
